Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Emanuel

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Indian Journal of Thoracic and Cardiovascular Surgery|October 16, 2020
A review of hybrid coronary revascularizationMichael Owen Kayatta, Michael Emanuel Halkos
Lancet (London, England)|September 4, 2012
Thalidomide and its sequelaeMichael Emanuel, Michael Rawlins, Gordon Duff, et al.
Indian Journal of Thoracic and Cardiovascular Surgery|October 16, 2020
Minimally invasive coronary artery bypass graftingMichael Owen Kayatta, Michael Emanuel Halkos, Pradeep Narayan
American Journal of Perinatology|June 21, 2016
Grouping Parturients by Parity, Previous-Cesarean, and Mode of Delivery (P-C-MoD Classification) Better Identifies Groups at Risk for Postpartum HemorrhageOrna Reichman, Micahel Gal, Hen Y Sela, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|January 29, 2026
Recombinant Human Amelogenin Protein Enhances Tendon-To-Bone Healing in a Rat Rotator Cuff Tear ModelShany Ivon Markowitz, Shlomi Bulkowstein, Michael Emanuel, et al.
The Oncologist|February 8, 2021
Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple MyelomaDickran Kazandjian, Alexander Dew, Elizabeth Hill, et al.
JAMA Oncology|September 16, 2021
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled TrialDickran Kazandjian, Elizabeth Hill, Alexander Dew, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Indian Journal of Thoracic and Cardiovascular Surgery|October 16, 2020
A review of hybrid coronary revascularizationMichael Owen Kayatta, Michael Emanuel Halkos
Lancet (London, England)|September 4, 2012
Thalidomide and its sequelaeMichael Emanuel, Michael Rawlins, Gordon Duff, et al.
Indian Journal of Thoracic and Cardiovascular Surgery|October 16, 2020
Minimally invasive coronary artery bypass graftingMichael Owen Kayatta, Michael Emanuel Halkos, Pradeep Narayan
American Journal of Perinatology|June 21, 2016
Grouping Parturients by Parity, Previous-Cesarean, and Mode of Delivery (P-C-MoD Classification) Better Identifies Groups at Risk for Postpartum HemorrhageOrna Reichman, Micahel Gal, Hen Y Sela, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|January 29, 2026
Recombinant Human Amelogenin Protein Enhances Tendon-To-Bone Healing in a Rat Rotator Cuff Tear ModelShany Ivon Markowitz, Shlomi Bulkowstein, Michael Emanuel, et al.
The Oncologist|February 8, 2021
Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple MyelomaDickran Kazandjian, Alexander Dew, Elizabeth Hill, et al.
JAMA Oncology|September 16, 2021
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled TrialDickran Kazandjian, Elizabeth Hill, Alexander Dew, et al.
Pageof 1